Renaissance Technologies
ONCS

Renaissance Technologies’s OncoSec Medical Incorporated ONCS Stock Holding History

Renaissance Technologies’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,179
Closed -$41K – 4594
2022
Q4 		$41K Buy
24,179
+21,115
+689% +$118K ﹤0.01% 3842
2022
Q3 		$33K Sell
3,064
-250
-8% -$3.76K ﹤0.01% 3833
2022
Q2 		$54K Buy
3,314
+1,087
+49% +$20.9K ﹤0.01% 3987
2022
Q1 		$56K Sell
2,227
-9,108
-80% -$192K ﹤0.01% 3894
2021
Q4 		$239K Buy
11,335
+6,612
+140% +$224K ﹤0.01% 3442
2021
Q3 		$221K Sell
4,723
-13,073
-73% -$662K ﹤0.01% 3171
2021
Q2 		$1.1M Buy
17,796
+2,309
+15% +$210K ﹤0.01% 2626
2021
Q1 		$1.63M Buy
15,487
+991
+7% +$136K ﹤0.01% 2350
2020
Q4 		$2.06M Sell
14,496
-3,810
-21% -$406K ﹤0.01% 2100
2020
Q3 		$1.36M Buy
18,306
+2,167
+13% +$169K ﹤0.01% 2335
2020
Q2 		$728K Buy
16,139
+5,340
+49% +$227K ﹤0.01% 2708
2020
Q1 		$302K Buy
10,799
+1,775
+20% +$66.3K ﹤0.01% 2981
2019
Q4 		$359K Buy
9,024
+4,857
+117% +$220K ﹤0.01% 3018
2019
Q3 		$181K Buy
+4,167
New +$196K ﹤0.01% 3171
2018
Q1 		– Sell
-760
Closed -$272K – 3698
2017
Q4 		$272K Buy
+760
New +$266K ﹤0.01% 3048
2017
Q1 		– Sell
-432
Closed -$117K – 3520
2016
Q4 		$117K Sell
432
-284
-40% -$97.5K ﹤0.01% 3085
2016
Q3 		$269K Buy
716
+156
+28% +$59.7K ﹤0.01% 2989
2016
Q2 		$202K Buy
560
+363
+184% +$153K ﹤0.01% 3047
2016
Q1 		$111K Buy
+197
New +$84K ﹤0.01% 3198

Other funds holding ONCS

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's ONCS Position: Q1 2023 in Review

Renaissance Technologies sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 24,179 shares — an estimated $41K sold.

Renaissance Technologies first reported a position in ONCS in Q1 2016 and held it in 19 quarters. The position peaked at $2.06M in Q4 2020. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

  • Renaissance Technologies reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
  • Renaissance Technologies sold 24,179 OncoSec Medical Incorporated shares in Q1 2023, an estimated $41K.
  • Renaissance Technologies first reported a position in OncoSec Medical Incorporated in Q1 2016 and held it in 19 quarters.
  • Renaissance Technologies's OncoSec Medical Incorporated position peaked at $2.06M in Q4 2020.
  • 12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.